Humana is a health insurance giant that sells Medicare, Medicaid, and employer plans to about 17 million Americans, plus runs pharmacies and home-care services. Think of it as a toll booth on the US healthcare highway.
Money comes from insurance premiums, with revenue hitting USD 129.66B in 2025. But it's a razor-thin business—net margin was just 0.92% that year, and 2025's fourth quarter actually lost money.
Scale and government contracts (CMS, TRICARE) create switching costs, but rivals like UnitedHealth and CVS Health are squeezing margins with aggressive Medicare Advantage pricing. Moat is eroding as star ratings drop and costs rise.
Buy (sector percentile 77) — value A-, growth B, profitability C-, momentum B+, revisions A-. Updated daily, sector-relative, identical for every user.
Key events, in time order
Humana's deal with HealthStream backs 1,000 caregiver scholarships and new tools to improve retention in Indiana.
Adj EPS $7.61 beat, FY guide cut to at least $9, below consensus
Multiple independent sources confirm upgrade with sharply higher PT, citing easing MA cost trends
None yet
None yet
No comments yet.
Facts and opinions separated · All items sourced · Not investment advice
